Osteonecrosis of the jaw after treatment with bisphosphonates

British Medical Journal

Volumn 333, Issue 7576, 2006, Pages 982-983

  Landis, Basile Nicolas ^a   Richter, Michel ^a   Dojcinovic, Ivan ^a   Hugentobler, Max ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ANTIANGIOGENIC ACTIVITY; AVASCULAR NECROSIS; BONE NECROSIS; CLINICAL FEATURE; DEBRIDEMENT; EDITORIAL; HUMAN; JAW DISEASE; LONG TERM CARE; MOUTH HYGIENE; OSTEOCLAST; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME; CHEMICALLY INDUCED DISORDER;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; JAW DISEASES; OSTEONECROSIS;

EID: 33750944408     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39024.647558.BE     Document Type: Editorial

References (8)

1. Drake WM, Kendler DL, Brown JP. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual foothills meeting on osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000. Clin Ther 2001;23:620-6.
2. Wood J, Bonjean K, Ruetz S, Bellahcene A, Devy L, Foidart JM, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302:1055-61.
3. Lin JH, Russell G, Gertz B. Pharmacokinetics of alendronate: an overview. Int J Clin Pract 1999;101(suppl):18-26.
4. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7.
5. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroft SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac. Surg 2004;62:527-34.
6. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-75.
7. Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144:753-61.
8. Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, et al. Osteonecrosis of the mandible or maxilla associated with the use of new generation biphosphonates. Laryngoscope 2006;116:115-20.